## **Core Concept**
The question tests the understanding of the autonomic nervous system (ANS) and its pharmacological modulation. The ANS has two main divisions: the **sympathetic nervous system** and the **parasympathetic nervous system**. Drugs can selectively or non-selectively act on these divisions.

## **Why the Correct Answer is Right**
The correct answer, , typically refers to a drug or agent that can affect both the sympathetic and parasympathetic divisions of the autonomic nervous system. One classic example of such agents is **non-selective beta blockers** or certain anticholinesterases, but most broadly, ** atropine and certain ganglion blockers** can affect both. However, a commonly known substance acting on both is **acetylcholine** itself, as it is a neurotransmitter for both the parasympathetic nervous system and the **sympathetic** nervous system's **preganglionic neurons**.

## **Why Each Wrong Option is Incorrect**
- **Option A:** If this option refers to a drug that selectively acts on the sympathetic nervous system, such as a beta-1 selective beta blocker, it would not be correct because it doesn't act on both divisions.
- **Option B:** If this option refers to a drug that acts specifically on the parasympathetic nervous system, like an anticholinergic that only blocks muscarinic receptors, it wouldn't be correct because it doesn't have a broad action on both divisions.
- **Option D:** If this option refers to a drug with no effect on the autonomic nervous system or acts selectively on either division without affecting the other, it would be incorrect.

## **Clinical Pearl / High-Yield Fact**
A high-yield fact to remember is that **ganglion blockers** (like trimethaphan) can block both sympathetic and parasympathetic ganglia, affecting both divisions. Also, recall that **acetylcholine** is the primary neurotransmitter released by **preganglionic neurons** of both the sympathetic and parasympathetic nervous systems.

## **Correct Answer:** . Atropine